Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Capital Expenditures (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Capital Expenditures for 10 consecutive years, with $599000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 104.12% to $599000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $11.1 million, a N/A change, with the full-year FY2025 number at $11.1 million, changed N/A from a year prior.
  • Capital Expenditures was $599000.0 for Q4 2025 at Orthopediatrics, down from $2.8 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $6.7 million in Q2 2024 to a low of -$14.5 million in Q4 2024.
  • A 5-year average of $2.3 million and a median of $2.8 million in 2021 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: soared 833.46% in 2023, then plummeted 478.65% in 2024.
  • Orthopediatrics' Capital Expenditures stood at $1.6 million in 2021, then tumbled by 131.99% to -$523000.0 in 2022, then skyrocketed by 833.46% to $3.8 million in 2023, then tumbled by 478.65% to -$14.5 million in 2024, then soared by 104.12% to $599000.0 in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Capital Expenditures are $599000.0 (Q4 2025), $2.8 million (Q3 2025), and $3.4 million (Q2 2025).